Figure 7. Connection among prognostic risk model and immune or cancer-related characteristics of HCC patients. (A) Significant differences in expression of immune checkpoints between the two groups. (B) The enrichment level of cancer-related signatures in the two groups. (C) Immune-related pathways enriched in the high-risk group. The correlation between genes in prognostic risk model and the infiltration level of 23 immune cells (D) and immune-related pathway (E). Red for positive associations and green for negative associations. Abbreviation: HCC: hepatocellular carcinoma. *p < 0.05; **p < 0.01; ***p < 0.001.